Common misconceptions

Common mistake
Wrong: Fatty acid synthesis occurs in the mitochondrial matrix, the same location as beta-oxidation.
Right: Fatty acid synthesis occurs in the cytosol, while beta-oxidation occurs in the mitochondrial matrix.
Beta-oxidation takes place in the mitochondrial matrix because that's where the relevant enzymes and CoA thioesters operate, but fatty acid synthesis uses an entirely separate set of cytosolic enzymes organized into the fatty acid synthase (FAS) multienzyme complex. These two pathways are physically separated to allow independent regulation — the cell can degrade fat in the mitochondria while synthesizing it in the cytosol under the right conditions. Whenever a question describes fatty acid synthesis, default to cytosol.
Common mistake
Wrong: Fatty acid synthesis uses NADH as the reducing equivalent, mirroring the NADH produced in beta-oxidation.
Right: Fatty acid synthesis uses NADPH (primarily from the pentose phosphate pathway) as the reducing equivalent.
NADH and NADPH look nearly identical but serve different metabolic roles: NADH feeds the electron transport chain for ATP production, while NADPH is reserved for reductive biosynthesis. Fatty acid synthesis requires reduction steps to build the carbon chain, and those reductions specifically use NADPH — primarily supplied by the pentose phosphate pathway. The fact that beta-oxidation produces NADH (and FADH2) is a useful memory hook: synthesis is the reverse in spirit, so it consumes the 'other' reduced nicotinamide, NADPH.
Common mistake
Wrong: Acetyl-CoA carboxylase (ACC) is activated by palmitoyl-CoA and inhibited by citrate.
Right: ACC is activated by citrate (signaling energy abundance) and inhibited by palmitoyl-CoA (product feedback) and glucagon/epinephrine via PKA phosphorylation.
The logic of ACC regulation follows energy status: citrate accumulates when the TCA cycle is backed up (plenty of acetyl-CoA, plenty of energy), signaling that it's safe to store fat — so citrate activates ACC. Palmitoyl-CoA is the end product of synthesis, so when it builds up, it feedback-inhibits ACC to prevent overproduction. Glucagon and epinephrine signal fasting/stress states where fat storage is counterproductive, so they activate PKA, which phosphorylates and inhibits ACC. Reversing these regulators is a classic MCAT trap.
Common mistake
Gap: Unaware that acetyl-CoA requires the citrate shuttle to reach the cytosol for fatty acid synthesis
Acetyl-CoA cannot cross the inner mitochondrial membrane directly; it is exported to the cytosol as citrate via the citrate shuttle, then regenerated by ATP-citrate lyase.
Acetyl-CoA is a charged, CoA-bound molecule that cannot diffuse across the inner mitochondrial membrane. Instead, acetyl-CoA condenses with oxaloacetate in the matrix to form citrate, which is transported out via the citrate transporter. Once in the cytosol, ATP-citrate lyase cleaves citrate back into acetyl-CoA and oxaloacetate, regenerating the substrate for fatty acid synthesis. This shuttle also explains why citrate is both a TCA intermediate and an allosteric activator of ACC — high cytosolic citrate directly signals substrate availability for synthesis.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know that fatty acid synthesis is cytosolic — acetyl-CoA cannot cross the inner mitochondrial membrane directly and must be exported as citrate via the citrate shuttle, then regenerated by ATP-citrate lyase in the cytosol.
  2. Identify acetyl-CoA carboxylase (ACC) as the rate-limiting enzyme; know it uses biotin as a cofactor, is activated allosterically by citrate, and is inhibited by palmitoyl-CoA and by PKA-mediated phosphorylation (triggered by glucagon or epinephrine).
  3. Know that NADPH — primarily sourced from the pentose phosphate pathway — is the reducing equivalent for fatty acid synthesis, and be able to explain why NADH is not used here.
  4. Contrast fatty acid synthesis with beta-oxidation across all key dimensions: location (cytosol vs. mitochondrial matrix), reducing equivalents (NADPH vs. FAD/NAD+), carrier (ACP vs. CoA), and building block (malonyl-CoA vs. acetyl-CoA cleavage).

Can you avoid these mistakes?

A well-fed cell has high insulin and abundant glucose. Trace the path of a carbon from dietary glucose to a palmitate chain — name the compartments it passes through, the key intermediates, and at least two enzymes involved in the synthesis portion.
A researcher treats hepatocytes with glucagon. Predict what happens to malonyl-CoA levels and explain the enzyme-level mechanism behind your prediction.
A passage describes an enzyme that requires biotin, is inhibited by its own product, and catalyzes the committed step of a biosynthetic pathway. What pathway is this, what is the enzyme, and what molecule activates it?
Without looking at notes, list three ways fatty acid synthesis and beta-oxidation differ — one related to location, one to electron carriers, and one to the carbon carrier (CoA vs. ACP). Then explain why these differences matter for independent regulation.

Related topics

See how your Anki deck covers this topic.

Upload your deck for a free audit →